Notably, the interaction of LAG-3 with LSECtin, expressed in melanoma cells, leads to the inhibition of IFN-γ secretion by effector T cells, while GAL-3, another potential ligand, suppresses CD8+ T cells and DCs. The gene discussed is LAG3; the disease is melanoma.